Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02844933 |
|
Recruitment Status :
Terminated
(Insys Therapeutics filed Chapter 11 and terminated all studies.)
First Posted : July 26, 2016
Last Update Posted : November 13, 2020
|
Sponsor:
Benuvia Therapeutics Inc.
Information provided by (Responsible Party):
Benuvia Therapeutics Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 10, 2019 |
| Actual Study Completion Date : | June 10, 2019 |